Muhammad Mujtaba Bhinder, Ammad Naeem, Mohammad Khudayar, Abdullah Sohail, Amir Kamran. "Comparing the bleeding risk in hepatocellular carcinoma patients treated with atezolizumab/bevacizumab versus durvalumab plus tremelimumab.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e13882